furazolidone has been researched along with Cardiomyopathies in 19 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol is a non-selective beta-blocker with alpha-receptor blockade and antioxidant properties." | 5.32 | Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure. ( Doye, AA; Gwathmey, JK; Hajjar, RJ; Jabbour, G; Laste, N; Lebeche, D; Lee, MX; Okafor, CC; Perreault-Micale, C; Skiroman, K, 2003) |
| "We have previously demonstrated that in furazolidone-induced congestive heart failure in turkeys the specific Ca(2+)-ATPase activity of myocardial sarcoplasmic reticulum (SR) is 60% increased in compensation for a 50% depression in net Ca(2+)-sequestration activity." | 3.68 | Myocardial calcium cycling defect in furazolidone cardiomyopathy. ( Julian, RJ; Mirsalimi, SM; O'Brien, PJ; Shen, H; Weiler, JE, 1991) |
| "Carvedilol is a non-selective beta-blocker with alpha-receptor blockade and antioxidant properties." | 1.32 | Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure. ( Doye, AA; Gwathmey, JK; Hajjar, RJ; Jabbour, G; Laste, N; Lebeche, D; Lee, MX; Okafor, CC; Perreault-Micale, C; Skiroman, K, 2003) |
| "Newly hatched male White Pekin ducklings were fed furazolidone (FZ) at dosage of 750 mg/kg of feed for 4 weeks." | 1.27 | Furazolidone-induced congestive cardiomyopathy in ducklings: myocardial ultrastructural alterations. ( Ferrans, VJ; Van Vleet, JF, 1983) |
| "Furazolidone (700 ppm) was fed to turkey poults from 2 to 5 weeks of age." | 1.27 | Influence of thiamin supplements on furazolidone-induced cardiomyopathy in turkey poults. ( Ali, BH; Czarnecki, CM, 1987) |
| "1." | 1.26 | Role of taurine in furazolidone-induced cardiomyopathy. ( Czarnecki, CM; McClune, J; Schaffer, SW, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (89.47) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okafor, CC | 1 |
| Perreault-Micale, C | 1 |
| Hajjar, RJ | 1 |
| Lebeche, D | 1 |
| Skiroman, K | 1 |
| Jabbour, G | 1 |
| Doye, AA | 1 |
| Lee, MX | 1 |
| Laste, N | 1 |
| Gwathmey, JK | 1 |
| Schaffer, SW | 1 |
| Czarnecki, CM | 10 |
| McClune, J | 1 |
| Evanson, OA | 3 |
| Ali, BH | 3 |
| Mustafa, AI | 1 |
| Idris, SO | 1 |
| Mahdi, BM | 1 |
| Abu Elgasim, AI | 1 |
| Powers, MD | 1 |
| Good, AL | 1 |
| Van Vleet, JF | 4 |
| Ferrans, VJ | 4 |
| Limas, CJ | 1 |
| Einzig, S | 1 |
| Noren, G | 1 |
| Jegers, A | 1 |
| Jankus, EF | 1 |
| O'Brien, PJ | 1 |
| Shen, H | 1 |
| Weiler, JE | 1 |
| Mirsalimi, SM | 1 |
| Julian, RJ | 1 |
3 reviews available for furazolidone and Cardiomyopathies
| Article | Year |
|---|---|
Cardiomyopathy in turkeys.
Topics: Aging; Animals; Blood Proteins; Calcium; Cardiomyopathies; Cortisone; Electrocardiography; Female; F | 1984 |
Animal models of drug-induced cardiomyopathy.
Topics: Animals; Cardiomyopathies; Daunorubicin; Disease Models, Animal; Doxorubicin; Electrocardiography; E | 1984 |
Some pharmacological and toxicological properties of furazolidone.
Topics: Adrenal Glands; Alcoholism; Animals; Anorexia; Brain; Cardiomyopathies; Cattle; Chick Embryo; Chicke | 1983 |
16 other studies available for furazolidone and Cardiomyopathies
| Article | Year |
|---|---|
Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Apoptosis; Carbazo | 2003 |
Role of taurine in furazolidone-induced cardiomyopathy.
Topics: Animals; Body Weight; Cardiomyopathies; Drinking; Electrocardiography; Furazolidone; Taurine; Turkey | 1982 |
Myocardial calcium levels in furazolidone-induced cardiomyopathy in turkey poults.
Topics: Animals; Calcium; Cardiomyopathies; Furazolidone; Myocardium; Poultry Diseases; Turkeys | 1983 |
Furazolidone poisoning associated with cardiomyopathy in chickens.
Topics: Acute Disease; Animals; Cardiomyopathies; Chickens; Furazolidone; Poultry Diseases | 1984 |
Monoamine oxidase inhibition and furazolidone-induced cardiomyopathy in turkey poults.
Topics: Animals; Cardiomyopathies; Depression, Chemical; Diet; Electrocardiography; Furazolidone; Kidney; Li | 1983 |
Congestive cardiomyopathy induced in ducklings fed graded amounts of furazolidone.
Topics: Animals; Cardiomyopathies; Diet; Ducks; Food Additives; Furazolidone; Male; Myocardium; Poultry Dise | 1983 |
Furazolidone-induced congestive cardiomyopathy in ducklings: regression of cardiac lesions after cessation of furazolidone ingestion.
Topics: Animals; Cardiomyopathies; Disease Models, Animal; Ducks; Furazolidone; Heart Failure; Male; Myocard | 1983 |
Furazolidone-induced congestive cardiomyopathy in ducklings: myocardial ultrastructural alterations.
Topics: Animals; Cardiomyopathies; Ducks; Furazolidone; Heart Failure; Male; Myocardium; Myofibrils; Poultry | 1983 |
Furazolidone-induced congestive cardiomyopathy in ducklings: lack of protection from selenium, vitamin E, and taurine supplements.
Topics: Animals; Cardiomyopathies; Ducks; Furazolidone; Heart Failure; Male; Poultry Diseases; Selenium; Tau | 1983 |
Contrasting effects of spontaneous and induced cardiomyopathy on the nucleoproteins of turkey hearts.
Topics: Animals; Cardiomyopathies; Cell Nucleus; Disease Models, Animal; Furazolidone; Hemodynamics; Myocard | 1982 |
Distribution of myocardial glycogen in turkey poults during development of furazolidone-induced cardiomyopathy.
Topics: Animals; Cardiomyopathies; Furazolidone; Glycogen; Myocardium; Poultry Diseases; Turkeys | 1980 |
Characterization of glycogen in selected tissues of turkey poults with spontaneous round heart disease and furazolidone-induced cardiomyopathy.
Topics: Animals; Cardiomyopathies; Furazolidone; Glucose; Glycogen; Glycogen Storage Disease; Glycogen Stora | 1978 |
Myocardial calcium cycling defect in furazolidone cardiomyopathy.
Topics: Animals; Calcium; Calcium Channels; Calcium-Transporting ATPases; Cardiomyopathies; Disease Models, | 1991 |
Influence of thiamin supplements on furazolidone-induced cardiomyopathy in turkey poults.
Topics: Animals; Body Weight; Cardiomyopathies; Eating; Electrocardiography; Furazolidone; Poultry Diseases; | 1987 |
Quantitative morphological alterations during the development of furazolidone-induced cardiomyopathy in turkeys.
Topics: Age Factors; Animals; Body Weight; Cardiomyopathies; Cell Nucleus; Cytoplasm; Electrocardiography; F | 1986 |
Changes in myocardial ultrastructure during development of furazolidone-induced cardiomyopathy in turkeys.
Topics: Age Factors; Animals; Cardiomyopathies; Furazolidone; Glycogen; Lipid Metabolism; Lysosomes; Microsc | 1986 |